Atlas FDA

Linx Reflux Management System

FDA premarket approval P100049/S020 · decided 2018-01-29

Approval details

PMA number
P100049
Supplement
S020
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
Linx Reflux Management System
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2017-11-15
Decision date
2018-01-29
Days to decision
75 days
Decision code
APPR
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.